Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TaiDoc TechnologyTPE:4736 -2.06%68 EV-to-EBITDA is 4.34 as of Aug. 23, 2026, which is 44% below its 10-year median of 7.78. GuruFocus rates TPE:4736 with a GF Score™ of 68/100 and a GF Value™ of NT$119.19 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 516 Medical Devices & Instruments companies, TaiDoc Technology ranks better than 90.31% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, TaiDoc Technology's enterprise value is NT$9,538 Mil.
TaiDoc Technology's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was NT$2,200 Mil. Therefore, TaiDoc Technology's EV-to-EBITDA for today is 4.34.
The historical rank and industry rank for TaiDoc Technology's EV-to-EBITDA or its related term are showing as below:
TPE:4736'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.82 Med: 7.78 Max: 20.73
Current: 4.34
During the past 13 years, the highest EV-to-EBITDA of TaiDoc Technology was 20.73. The lowest was 2.82. And the median was 7.78.
TPE:4736's EV-to-EBITDA is ranked better than 90.31% of 516
companies
in the Medical Devices & Instruments industry
Industry Median: 14.65
vs TPE:4736: 4.34
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
TaiDoc Technology's PE Ratio (TTM) for today is calculated as:
TaiDoc Technology's share price for today is NT$142.50.
TaiDoc Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$18.160.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for TaiDoc Technology's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:4736 vs ABT, SYK, MDT: EV-to-EBITDA Comparison
For the Medical Devices subindustry, TaiDoc Technology's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TaiDoc Technology EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, TaiDoc Technology's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where TaiDoc Technology's EV-to-EBITDA falls into.
TaiDoc Technology's current Enterprise Value is NT$9,538 Mil.
TaiDoc Technology's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$2,200 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TaiDoc Technology (TPE:4736) has a EV-to-EBITDA of 4.34 as of Aug. 23, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on TaiDoc Technology. This is 44% below median its historical median of 7.78. Over the past decade, TaiDoc Technology's EV-to-EBITDA has ranged from 2.82 to 20.73. According to the industry distribution chart, TaiDoc Technology ranks #50 out of 516 companies in the Medical Devices & Instruments industry, placing it in the top 9.7%.
Is TaiDoc Technology's EV-to-EBITDA too high?
TaiDoc Technology's current EV-to-EBITDA of 4.34 is 44% below median its 10-year median of 7.78. Over the past 10 years, this metric has ranged from a low of 2.82 to a high of 20.73. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.65. TaiDoc Technology's value of 4.34 is 70.4% below this industry median. Based on the distribution chart, TaiDoc Technology ranks #50 out of 516 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, TaiDoc Technology has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does TaiDoc Technology's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, TaiDoc Technology ranks #50 out of 516 companies for EV-to-EBITDA. This places TaiDoc Technology in the top 10% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 14.65. TaiDoc Technology's value of 4.34 is 70.4% below this benchmark. Historically, TaiDoc Technology's own EV-to-EBITDA has ranged from 2.82 to 20.73 over the past decade. While the company's 10-year median is 7.78 vs. the industry median of 14.65, TaiDoc Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.65, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TaiDoc Technology's current EV-to-EBITDA of 4.34 is 70.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on TaiDoc Technology. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TaiDoc Technology's current EV-to-EBITDA is 4.34, which is 44% below median its own 10-year median of 7.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TaiDoc Technology stock overvalued right now?
Based on GuruFocus' analysis, TaiDoc Technology (TPE:4736) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$119.19, compared to a current price of NT$142.50 — trading 19.6% above its estimated fair value. The current EV-to-EBITDA is 4.34, which is 44% below median its 10-year median of 7.78 and 70.4% below the Medical Devices & Instruments industry median of 14.65. TaiDoc Technology's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For TaiDoc Technology (TPE:4736), the current EV-to-EBITDA is 4.34 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TaiDoc Technology (TPE:4736) Overvalued in 2026?
Based on GuruFocus' analysis, TaiDoc Technology stock appears to be overvalued.
The current stock price of NT$142.50 is trading 19.6% above its estimated GF Value™ of NT$119.19.
GuruFocus considers TaiDoc Technology to be Modestly Overvalued.
Key valuation signals for TPE:4736:
EV-to-EBITDA: 4.34 (44% below median its 10-year median of 7.78)
GF Value™: NT$119.19 vs. price of NT$142.50 (19.6% above fair value)
Industry Position: 70.4% below the Medical Devices & Instruments median (#50 of 516)
No single metric tells the full story. See the TPE:4736 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TaiDoc Technology Corp is engaged in the research and development, manufacture, and sales of various electronics components and medical devices. Its products and services include In Vitro Diagnostic, Medical Device, and TeleHealth. It has three segments: Manufacturing of Medical Devices, Precision Finishing Division, and Sales of Medical Devices. It derives the majority of its revenue from the Manufacturing of Medical Devices. Geographically, the company derives its key revenue from Europe and the rest from the Americas, the Middle East, Asia, Taiwan, and others.
68GF Score
Get the complete analysis for TPE:4736
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4736 has been successfully added to your 
